Translational Research Coordinator
- Job Title
- Translational Research Coordinator
- Job ID
- 27739330
- Location
- Grand Rapids, MI, 49546
- Other Location
- Description
-
XenoSTART, the preclinical division of START is a translational research organization focused on creating relevant preclinical cancer models. Our xenograft models represent each cancer type and disease stage and are established from patients at our domestic and international cancer centers. The XenoSTART Patient-Derived Xenograft (XPDX) platform includes over 2,500 models annotated with each donor patient’s cancer treatment and outcome data and characterized using IHC, DNA/RNA sequencing, and relevant in vivo drug efficacy.
Our XPDX models are clinically annotated and include patient treatment history and outcome and are characterized through genomic profiling, histologic analysis, and in vivo drug sensitivity to relevant standards of care. These models may be utilized in the following manner:
- In vivo PK/PD and efficacy studies
- In vivo efficacy panel screens (indication or target focused)
- In licensing of models for internal studies
- Custom model development
- Orthotopic and radiotherapy studies
- Ex vivo and organoid studies
We are hiring a Translational Research Coordinator at our XenoSTART location in Grand Rapids, MI. This role, under direct supervision of the Director, is responsible for assisting in the collection and shipment of samples and data maintenance for the START Xenograft Protocol. This includes patient consents, sample collection and shipment, implant and XPDX model tracking. In addition, this position serves to assist in identifying patients with treatment profiles important for future drug development.
Essential Responsibilities- Organize and manage consents for the START Xenograft Protocol including individuals assisting in the consent process. Inform physicians when consents from patient needed.
- Sample collection, shipment, and implant tracking: Collects samples by vehicle from various locations and processes as needed. Ships samples to a designated location following specific protocols. Tracks implants and resulting XPDX models.
- Patient and model data collection and presentation: Identifies patients with treatment profiles important for future drug development. Provides relevant results from XPDX models to researchers and physicians in HIPAA-compliant manner.
- Works closely with the START Center, other START sites, collaborator physicians, researchers and personnel to facilitate adherence to established protocols for consenting, sample collection and delivery, and provides updates as needed.
Education & Experience- Bachelor’s degree required, preferably with a science or business focus.
- Knowledge of in vivo preclinical research preferred.
- Must be familiar with Microsoft Office applications.
- Good record keeping and ability to work in a fast-paced team environment is a must.
- Valid state driver’s license, active, up to date vehicle car insurance and a good driving record required for this position.
Best-in-Class Benefits and Perks
We value our employees’ time and efforts. Our commitment to your success is enhanced by a competitive compensation, depending on experience, and an extensive benefits package including:- Comprehensive health coverage: Medical, dental, and vision insurance provided
- Robust retirement planning: 401(k) plan available with employer matching
- Financial security: Life and disability insurance for added protection
- Flexible financial options: Health savings and flexible spending accounts offered
- Well-being and work-life balance: Paid time off, flexible schedule, and remote work choices provided
- Plus, we work to maintain the best environment for our employees, where people can learn and grow with the company. We strive to provide a collaborative, creative environment where everyone feels encouraged to contribute to our processes, decisions, planning, and culture.
More about The START Center for Cancer Research
Deeply rooted in community oncology centers globally, The START Center for Cancer Research provides access to specialized preclinical and early-phase clinical trials of novel anti-cancer agents. START clinical trial sites have conducted more than a thousand early-phase clinical trials, including for 43 therapies that were approved by the FDA. START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. Learn more at STARTresearch.com.
Ready to be part of a team changing the future of cancer treatment?
Join us in our mission to conquer cancer, one clinical trial at a time. Your expertise and dedication can help us bring hope and healing to patients worldwide. Please submit your application online.
We are an equal opportunity employer that welcomes and encourages diversity in the workplace. We do not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
